DaAron Foundation
2024 Hematology Oncology Conference
- Registration Closed
Target Audience
This activity is designed to meet the educational needs Interprofessional team of oncology nurses, physician associates, nurse practitioners, and physician extenders providing care to oncology patients.
Learning Objectives
After completing this conference, learners will be able to:
Appraise emerging therapies and diagnostic technologies in selected hematology-oncology
Discuss multidisciplinary personalized treatment approaches in selected hematological malignancies
Foster clinical applications of skills in clinical and translational research
Click to download Agenda
| The Power of Precision in Personalized Hematology Oncology Care
A Two-Day Conference to Invigorate, Challenge, and Advance Hematology Oncology!
Houston Marriott Medical Center/Museum District 6580 Fannin Street, Houston, TX 77030 Friday, April 12th, 2024 5:00 PM – 8:30 PM Saturday, April 13th, 07:00 AM – 2:30 PM | |||
| To receive contact hours for this nursing continuing professional development activity, the participant must:
•Attend and be present for the entire presentation. No partial credit will be provided. •Complete the evaluation after the presentation via link provided to all participants. •Certificates will be awarded electronically upon completion of the evaluation. Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 7.0 NCPD contact hours, including 2.5 pharmacotherapeutic contact hours. | |||
| Friday April 12th Schedule | Credit | ||
| Time | Topics | Speakers | |
| 1700 - 1730 | Welcome/Registration/Networking | ||
| 17:30 - 17:45 | Welcome/Reception/Networking | ||
| 17:45 - 18:00 | Introduction/NCPD Information/Disclosures | Roselyn Ogunkunle | |
| 18:00 - 19:00 | Cancer-Associated VTE: Balancing Risk and Reward with Modern Anticoagulation (By CEConcepts) | Andrea Van Beek, DNP, APRN, AGPCNP-BC, CACP | |
| 19:00 - 20:00 | Drug update in Hematology Oncology | Brian Dinh Oncology Clinical Pharmacist Specialist at Memorial Hermann Health System | |
| 20:00 - 2015 | Evaluation/Wrap up/Information for April 13th | Roselyn Ogunkunle | |
| Saturday April 13th Schedule | |||
| Times | Topics | Speakers | |
| 7:00 - 07:30 | Registration/Breakfast | ||
| 7:30 - 7:45 | Introductions/NCPD/Disclosures | Roselyn Ogunkunle | |
| 07:45 - 08:15 | Acute Myeloid Leukemia: Innovations and Advances in AML | Shilpan Shah, MD Hematologic Malignancy, Hematology, Medical Oncology Houston Methodist | |
| 08:15 - 08:45 | DLBCL: Advances and Insights in Diffuse Large B-Cell Lymphoma Treatment | Sai Pingali, MD Cellular Therapy, Hematologic Malignancy and Hematology Houston Methodist | |
| 08:45 - 09:00 | Break | ||
| 09:00 - 09:30 | Navigating the Journey: Breakthroughs and Strategies in Chronic Lymphocytic Leukemia (CLL) Care - Part 1 | Shilpan Shah, MD Hematologic Malignancy, Hematology, Medical Oncology Houston Methodist | |
| 09:30 - 10:00 | Navigating the Journey: Breakthroughs and Strategies in Chronic Lymphocytic Leukemia (CLL) Care - Part 2 | Jenny Morrow APRN Oncology Consultants | |
| 10:00 - 10:15 | Break | ||
| 10:15 - 10:45 | Turning the Tide Against Acute Lymphocytic Leukemia (ALL) | Adan Rios, MD Medical Oncology UT Physicians/Memorial Hermann | |
| 10:45 - 11:15 | Shaping a New Horizon: Transformative Approaches in the Battle Against Sickle Cell Disease | Johanne Pierre APRN Adult-Gerontology Acute Care Nurse Practitioner Oncology Consultants | |
| 11:15 - 12:00 | Lunch Break | ||
| Lunch Presentation | A Comprehensive Overview of Immune Thrombocytopenia (Podium sponsored by Sobi) Ballroom A | Veena Chandrakar, M.D. Medical Oncology, Hematology Oncology Consultants | No CE |
| Lunch Presentation | Guiding the Path of Care – A Peer-led discussion exploring the AML disease state and approach to treatment (Podium sponsored by AbbVie) Ballroom B | Mary E. Peterson, MS, APRN, AOCNP, FAPO Oncology Nurse Educator - Texas Hematology/Oncology - AbbVie | No CE |
| 12:00 - 12:30 | Emerging Frontiers in the Management of Myeloproliferative Neoplasms (MPNs) | Julie Huynh-Lu PA-C Supervisor, Advanced Practice Provider - Leukemia UT MD Anderson Cancer Center | |
| 12:30 - 13:00 | Understanding Multiple Myeloma: Insights and Advances | Siddhartha Ganguly, MD, FACP Associate Director for Clinical Investigation, Carol Cockrell Curran Distinguished Centennial Chair in Hematologic Oncology, Chief, Section of Hematology at Houston Methodist | |
| 13:00 - 13:15 | Break | ||
| 13:15 - 13:45 | Evolving Therapies in Chronic Myeloid Leukemia (CML) | Ledian Memushaj APRN, AGACNP UT Physicians/Memorial Hermann | |
| 13:45 - 14:15 | CAR T-Cell Therapy: Revolutionizing Cancer Treatment | Siddhartha Ganguly, MD, FACP Associate Director for Clinical Investigation, Carol Cockrell Curran Distinguished Centennial Chair in Hematologic Oncology, Chief, Section of Hematology at Houston Methodist | |
| 14:15 - 14:30 | NCPD Evaluation/Wrap-Up | ||
| Agenda subject to change | |||
Brian Dinh, PharmD, BCOP
an Oncology Clinical Pharmacist Specialist
Memorial Hermann TMC Cancer Center
Brian Dinh, PharmD, BCOP is an Oncology Clinical Pharmacist Specialist at the Memorial Hermann TMC Cancer Center.
He completed his Doctor of Pharmacy at the University of Houston College of Pharmacy where he found his passion for Oncology Pharmacy.
After graduation, he completed a PGY-1 Pharmacy Practice Residency Program with Emphasis in Oncology at the Scott and White Medical Center in Temple, Texas.
He then went on to complete a PGY-2 Pharmacy Oncology Residency Program at the University of Oklahoma.
He returned home to Houston, TX to become an Oncology Clinical Pharmacist at Memorial Hermann Cancer Center in the Texas Medical Center, providing collaborative drug therapy management in the practice areas of malignant hematology and gastrointestinal cancer.
He is passionate about bridging the gap between patients and the cancer care they need to reach their health goals and preventable complications.
Nothing to Disclose
Shilpan Shah, MD
Hematologic Malignancy, Hematology, Medical Oncology
Houston Methodist Neal Cancer Center
Hematologic Malignancy, Hematology, Medical Oncology
Houston Methodist
Nothing to Disclose
Sai Pingali, MD
Cellular Therapy, Hematologic Malignancy and Hematology
Houston Methodist Neal Cancer Canter
Professional Services - Speaker with Cardinal Health.
Jenny Morrow APRN
APRN
Oncology Consultants
Nothing to Disclose
Adan Rios, MD
Medical Oncology
UT Physicians/Memorial Hermann
Nothing to Disclose
Johanne Pierre APRN
APRN
Oncology Consultants
Nothing to Disclose
Julie Huynh-Lu PA-C
Supervisor, Advanced Practice Provider - Leukemia
UT MD Anderson Cancer Center
Professional Services Speaker - Incyte and GSK
Siddhartha Ganguly, MD, FACP
Associate Director for Clinical Investigation, Carol Cockrell Curran Distinguished Centennial Chair in Hematologic Oncology, Chief, Section of Hematology at Houston Methodist
Houston Methodist Neal Cancer Center
Professional Services, Speaker - Pfizer, Kite, Ad Board at Bristol Myers Squibb and Sanofi
Ledian Memushaj APRN, AGACNP
Acute Care APRN- Hematology
UT Physicians/Memorial Hermann
Nothing to Disclose
Thank You, Exhibitors!
| Sobi North America - Podium sponsor | AbbVie - Podium Sponsor |
| AstraZeneca | Merck Hematology |
| Novartis | Daiichi Sankyo, Inc. |
| PharmaEssentia USA Corporation | Jazz Pharmaceuticals, Inc. |
| BeiGene | BMS |
| Biologics by McKesson | Manor Specialty Pharmacy |
| Merck Nursing Education |
